This review is a summary of a recent speaker event from AGW titled: Ustekinumab, A New Option for the Treatment of Crohn's Disease. The discussion was led by Professor Subrata Ghosh, Director of the Institute of Translational Medicine and Professor of Translational Medicine, University of Birmingham.
Please login below to download this issue (PDF)